Solans M; Serra L; Renart G; Osca-Gelis G; Comas R; Vilardell L; Gallardo D; Marcos-Gragera R "Incidence and survival of Hodgkin lymphoma patients in Girona (Spain) over three decades: a population-based study." European Journal of Cancer Prevention 26 (2017): S164-S169. Rubió-Casadevall,J.; Hernandez-Pujol, A.M.; Ferreira-Santos, M.C.; Morey-Esteve, G.; Vilardell, L.; Osca-Gelis, G.; Vilar-Coromina, N.; Marcos-Gragera, R. "Trends in incidence and survival analysis in non-melanoma skin cancer from 1994 to 2012 in Girona, Spain : a population based study." Cancer Epidemiology 14 (2016): 6-10. De Angelis R; Minicozzi P; Sant M; Dal Maso L; H. Brewster D; Osca-Gelis G; Visser O; Maynadié M; Marcos-Gragera R; Troussard X; Agius D; Roazzi P; Meneghini E; Monnereau A; EUROCARE-5 Working Group "Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study." European Journal of Cancer 51 (2015): 2254-2268. Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Lloveras N; Guàrdia R; Marcos-Gragera R "Is survival in myeloid malignancies really improving? A retrospective 15 year population-based study." Leukemia and Lymphoma 56 (2015): 895-902. Puig-Vives M; Osca-Gelis G; Camprubí-Font C; Vilardell ML; Izquierdo A; Marcos-Gragera R. "Proportion of breast cancer in women aged 50 to 69 years from Girona according to detection method." Medicina Clinica 143 (2014): 300-302. Milena Sant; Pamela Minicozzi; Morgane Mounier; Lesley Anderson; Hermann Brenner; Bernd Holleczek; Rafael Marcos-Gragera; Marc Maynadié; Alain Monnereau; Gemma Osca-Gelis; Otto Visser; Roberta De Angelis; EUROCARE-5 Working G "Survival for haematological malignancies in Europe 1997-2008 by region and age: results of a EUROCARE-5 population-based study." Lancet Oncology 15 (2014): 931-942. Rubió-Casadevall J; Borràs JL; Carmona C; Ameijide A; Osca G; Vilardell L; Izquierdo A; Galceran J; Marcos-Gragera R. "Temporal trends of incidence and survival of sarcoma of digestive tract including Gastrointestinal Stromal Tumours (GIST) in two areas of the north-east of Spain in the period 1981-2005: a population-based study." Clinical and Translational Oncology 16 (2014): 660-667. Pérez-García A; Osca G; Bosch-Vizcaya A; Kelleher N; Santos NY; Rodríguez R; González Y; Roncero JM; Coll R; Serrando M; Lloveras N; Tuset E; Gallardo D. "Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcription.." Human Immunology 74 (2013): 1219-1224. Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Lloveras N; Marcos-Gragera R "Population-based incidence of myeloid malignancies: fifteen years of epidemiological data in the province of Girona, Spain." Haematologica-The Hematology Journal 98 (2013): e95-e97. Puig-Vives M; Pollan M; Rue M; Osca-Gelis G; Saez M; Izquierdo A; Marcos-Gragera R "Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983-2007." The Breast 21 (2012): 646-651. Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Solé F; Marcos-Gragera R. "Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): a population based study, 1993-2007." Leukemia Research 36 (2012): 1262-1266. Visser O; Trama A; Maynadié M; Stiller C; Marcos-Gragera R; De Angelis R; Mallone S; Tereanu C; Allemani C; Ricardi U; Schouten HC; The RARECARE Working Group. "Incidence, survival and prevalence of myeloid malignancies in Europe." European Journal of Cancer 48 (2012): 3257-3266.
A Bosch-Vizcaya; R Rodriguez-Romanos; JB Nieto; R de la Cámara; S Brunet; C Vallejo5; G Osca-Gelis; C Martínez-Laperche; I Buño; Á Urbano-Ispizúa; M González; A Jiménez-Velasco; D Gallardo on behalf of the GvHD/Immunotherapy "Effect of mismatching for mHA UTA2-1 on clinical outcome after HLA-identical sibling donor allo-SCT." Bone Marrow Transplantation (2014): -.
Puig-Vives, M; Camprubi-Font, C; Osca-Gelis, G; Izquierdo, A; Pollan, M; Marcos-Gragera, R "Differences in incidence trends of estrogen receptor positive/negative breast tumours in the Girona province, 2000-2009." European Journal of Cancer 43 (2013): S314-S314.
Mallo M; Osca G; Solórzano J; Arenillas L; Florensa L; Solé F. "TET2 gene is not deleted in chronic myelomonocytic leukemia: a FISH retrospective study." Haematologica : the Hematology Journal 95 (2010): 1798-1800.